Cargando…

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer

Current MRI-guided adaptive radiotherapy (MRgART) workflows require fraction-specific electron and/or mass density maps, which are created by deformable image registration (DIR) between the simulation CT images and daily MR images. Manual density overrides may also be needed where DIR-produced resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shu-Hui, Han, Zhaohui, Leeman, Jonathan E., Hu, Yue-Houng, Mak, Raymond H., Sudhyadhom, Atchar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539763/
https://www.ncbi.nlm.nih.gov/pubmed/36212472
http://dx.doi.org/10.3389/fonc.2022.969463
_version_ 1784803560940109824
author Hsu, Shu-Hui
Han, Zhaohui
Leeman, Jonathan E.
Hu, Yue-Houng
Mak, Raymond H.
Sudhyadhom, Atchar
author_facet Hsu, Shu-Hui
Han, Zhaohui
Leeman, Jonathan E.
Hu, Yue-Houng
Mak, Raymond H.
Sudhyadhom, Atchar
author_sort Hsu, Shu-Hui
collection PubMed
description Current MRI-guided adaptive radiotherapy (MRgART) workflows require fraction-specific electron and/or mass density maps, which are created by deformable image registration (DIR) between the simulation CT images and daily MR images. Manual density overrides may also be needed where DIR-produced results are inaccurate. This approach slows the adaptive radiotherapy workflow and introduces additional dosimetric uncertainties, especially in the presence of the magnetic field. This study investigated a method based on a conditional generative adversarial network (cGAN) with a multi-planar method to generate synthetic CT images from low-field MR images to improve efficiency in MRgART workflows for prostate cancer. Fifty-seven male patients, who received MRI-guided radiation therapy to the pelvis using the ViewRay MRIdian Linac, were selected. Forty-five cases were randomly assigned to the training cohort with the remaining twelve cases assigned to the validation/testing cohort. All patient datasets had a semi-paired DIR-deformed CT-sim image and 0.35T MR image acquired using a true fast imaging with steady-state precession (TrueFISP) sequence. Synthetic CT images were compared with deformed CT images to evaluate image quality and dosimetric accuracy. To evaluate the dosimetric accuracy of this method, clinical plans were recalculated on synthetic CT images in the MRIdian treatment planning system. Dose volume histograms for planning target volumes (PTVs) and organs-at-risk (OARs) and dose distributions using gamma analyses were evaluated. The mean-absolute-errors (MAEs) in CT numbers were 30.1 ± 4.2 HU, 19.6 ± 2.3 HU and 158.5 ± 26.0 HU for the whole pelvis, soft tissue, and bone, respectively. The peak signal-to-noise ratio was 35.2 ± 1.7 and the structural index similarity measure was 0.9758 ± 0.0035. The dosimetric difference was on average less than 1% for all PTV and OAR metrics. Plans showed good agreement with gamma pass rates of 99% and 99.9% for 1%/1 mm and 2%/2 mm, respectively. Our study demonstrates the potential of using synthetic CT images created with a multi-planar cGAN method from 0.35T MRI TrueFISP images for the MRgART treatment of prostate radiotherapy. Future work will validate the method in a large cohort of patients and investigate the limitations of the method in the adaptive workflow.
format Online
Article
Text
id pubmed-9539763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95397632022-10-08 Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer Hsu, Shu-Hui Han, Zhaohui Leeman, Jonathan E. Hu, Yue-Houng Mak, Raymond H. Sudhyadhom, Atchar Front Oncol Oncology Current MRI-guided adaptive radiotherapy (MRgART) workflows require fraction-specific electron and/or mass density maps, which are created by deformable image registration (DIR) between the simulation CT images and daily MR images. Manual density overrides may also be needed where DIR-produced results are inaccurate. This approach slows the adaptive radiotherapy workflow and introduces additional dosimetric uncertainties, especially in the presence of the magnetic field. This study investigated a method based on a conditional generative adversarial network (cGAN) with a multi-planar method to generate synthetic CT images from low-field MR images to improve efficiency in MRgART workflows for prostate cancer. Fifty-seven male patients, who received MRI-guided radiation therapy to the pelvis using the ViewRay MRIdian Linac, were selected. Forty-five cases were randomly assigned to the training cohort with the remaining twelve cases assigned to the validation/testing cohort. All patient datasets had a semi-paired DIR-deformed CT-sim image and 0.35T MR image acquired using a true fast imaging with steady-state precession (TrueFISP) sequence. Synthetic CT images were compared with deformed CT images to evaluate image quality and dosimetric accuracy. To evaluate the dosimetric accuracy of this method, clinical plans were recalculated on synthetic CT images in the MRIdian treatment planning system. Dose volume histograms for planning target volumes (PTVs) and organs-at-risk (OARs) and dose distributions using gamma analyses were evaluated. The mean-absolute-errors (MAEs) in CT numbers were 30.1 ± 4.2 HU, 19.6 ± 2.3 HU and 158.5 ± 26.0 HU for the whole pelvis, soft tissue, and bone, respectively. The peak signal-to-noise ratio was 35.2 ± 1.7 and the structural index similarity measure was 0.9758 ± 0.0035. The dosimetric difference was on average less than 1% for all PTV and OAR metrics. Plans showed good agreement with gamma pass rates of 99% and 99.9% for 1%/1 mm and 2%/2 mm, respectively. Our study demonstrates the potential of using synthetic CT images created with a multi-planar cGAN method from 0.35T MRI TrueFISP images for the MRgART treatment of prostate radiotherapy. Future work will validate the method in a large cohort of patients and investigate the limitations of the method in the adaptive workflow. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9539763/ /pubmed/36212472 http://dx.doi.org/10.3389/fonc.2022.969463 Text en Copyright © 2022 Hsu, Han, Leeman, Hu, Mak and Sudhyadhom https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hsu, Shu-Hui
Han, Zhaohui
Leeman, Jonathan E.
Hu, Yue-Houng
Mak, Raymond H.
Sudhyadhom, Atchar
Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title_full Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title_fullStr Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title_full_unstemmed Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title_short Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
title_sort synthetic ct generation for mri-guided adaptive radiotherapy in prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539763/
https://www.ncbi.nlm.nih.gov/pubmed/36212472
http://dx.doi.org/10.3389/fonc.2022.969463
work_keys_str_mv AT hsushuhui syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer
AT hanzhaohui syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer
AT leemanjonathane syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer
AT huyuehoung syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer
AT makraymondh syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer
AT sudhyadhomatchar syntheticctgenerationformriguidedadaptiveradiotherapyinprostatecancer